Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Increasing COX-2 in mouse skin causes bigger sebaceous glands and thinner hair, but stopping COX-2 can reverse hair thinning.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Baricitinib is the most effective treatment for alopecia areata.

IND-Ca ointment effectively reduces inflammation with minimal skin irritation.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Canakinumab's effect on COVID-19 outcomes is unclear.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Brepocitinib reduces interferon signaling in hidradenitis suppurativa patients.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Rituximab may cause skin issues, but baricitinib can help improve them.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

A diabetic cat with another gland issue got better after treatment with cabergoline, no longer needing insulin.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

The gel with apocynin-loaded nanoparticles shows promise for treating rheumatoid arthritis.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib may help regrow hair in alopecia areata patients.